Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system

Yvonne L. Eaglehouse, Matthew W. Georg, Craig D. Shriver, Kangmin Zhu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Purpose: It is unclear whether time between breast cancer diagnosis and surgery is associated with survival and whether this relationship is affected by access to care. We evaluated the association between time-to-surgery and overall survival among women in the universal-access U.S. Military Health System (MHS). Methods: Women aged 18–79 who received surgical treatment for stages I–III breast cancer between 1998 and 2010 were identified in linked cancer registry and administrative databases with follow-up through 2015. Multivariable Cox regression models were used to estimate risk of all-cause death associated with time-to-surgery intervals. Results: The study included 9669 women with 93.1% survival during the study period. The hazards ratios (95% confidence intervals) of all-cause death associated with time-to-surgery were 1.15 (0.93, 1.42) for 0 days, 1.00 (reference) for 1–21 days, 0.97 (0.78, 1.21) for 22–35 days, and 1.30 (1.04, 1.61) for ≥ 36 days. The higher risk of mortality associated with time-to-surgery ≥ 36 days tended to be consistent when analyzed by surgery type, age at diagnosis, and tumor stage. Conclusions: In the MHS, longer time-to-surgery for breast cancer was associated with poorer overall survival, suggesting the importance of timeliness in receiving surgical treatment for breast cancer in relation to overall survival.

Original languageEnglish
Pages (from-to)441-450
Number of pages10
JournalBreast Cancer Research and Treatment
Volume178
Issue number2
DOIs
StatePublished - 1 Nov 2019
Externally publishedYes

Keywords

  • Breast surgery
  • Clinical outcomes
  • Lumpectomy
  • Mastectomy
  • Overall survival

Fingerprint

Dive into the research topics of 'Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system'. Together they form a unique fingerprint.

Cite this